Interrelationships between exogenous porcine somatotropin (PST) administration and dietary protein and energy intake on protein deposition capacity and energy metabolism of pigs

Exogenous porcine somatotropin (PST) administration stimulates protein deposition and inhibits lipogenesis, resulting in dose-related improvements in growth performance and reduction of carcass fat content. However, the associated impacts of this technology on dietary nutrient requirements and energy partitioning between maintenance, protein, and fat remain unclear. Studies with pigs between 25 and 60 kg body weight indicate that, because of unknown improvements in amino acid utilization and(or) in the energy available for protein synthesis, only marginal increases in dietary protein percentage are required to support 20 to 25% improvements in protein deposition induced by PST administration. In contrast, an increased dietary protein concentration is required to support maximal protein deposition in pigs 60 to 100 kg. Exogenous PST administration increased the maintenance energy requirement and altered the relationship between energy intake and protein deposition, although the magnitude of these changes and the consequent effects on expression of dietary protein (amino acid) requirements was influenced by gender. Albeit limited, information suggests that PST alters nutrient demand at the tissue level. Information of this type will form the basis for rational decisions concerning the method for expression of dietary nutrient requirements (% vs g/d) for PST-treated pigs. Further quantitative information is required on the effects of PST dosage on the relationship of protein deposition to energy intake and on any underlying changes in amino acid utilization and metabolism.     

Effect of sex and exogenous porcine somatotropin on longissimus muscle fiber characteristics of growing pigs

Thirty-seven pigs with an initial live weight of 60 kg were used to investigate the effects of daily exogenous porcine somatotropin (pST) administration at two dose levels (0 and 100 micrograms.kg-1.d-1) for a 31-d period on muscle fiber characteristics and meat tenderness of boars, gilts and barrows. Excipient boars and gilts had more alpha W and fewer alpha R fibers than did those receiving pST. The percentage of muscle fiber type for barrows was not affected by pST treatment. The administration of pST resulted in an increase in muscle fiber size for all three fiber types in all three sexes, but these changes were of greater magnitude in barrows (31.8%) and gilts (27.8%) than in boars (9.3%). Somatotropin negated the intrinsic sex effect differences in fiber area of the pigs. There was no difference in tenderness among excipient boars, barrows and gilts; however, with the inclusion of pST, shear force decreased in boars and gilts and increased in barrows. A high proportion of the pST-treated pigs contained giant fibers in the longissimus muscle. Furthermore, a small proportion of the pST-treated pigs exhibited pale, soft, exudative muscle. Whether the giant fiber anomalies occurred through increased muscle activity or from fibers undergoing degenerative changes was not determined.     

Effect of exogenous porcine somatotropin on the functional and textural characteristics of the porcine semimembranosus muscle

Sixteen barrows and gilts (sex effects were balanced within treatment, but not included in the model for analysis) were used in a 2 (porcine somatotropin; 2 mg.animal-1.d-1 vs control) X 2 (10% dietary fat vs control) X 4 (time postmortem; 0, 3, 6, and 24 h) factorial treatment array to evaluate the effects of porcine somatotropin (pST) administration and level of dietary fat intake on the functional and textural characteristics of the semimembranosus muscle during the first 24 h postmortem. Porcine somatotropin administration resulted in a decrease (P less than .05) in muscle tenderness, an increase (P less than .05) in chilled carcass weight, and an increase (P less than .08) in longissimus muscle area. The pH values were lower over time with elevated levels of dietary fat, but pST resulted in no alterations in muscle pH. The R-values (the ratio of inosine to adenine nucleotides) were unaffected by pST or by level of dietary fat, but the combination of the two resulted in an increase in moisture binding capabilities. It could be concluded from the present study that pST and increased level of dietary fat result in an alteration of certain functional (tenderness) and textural (water binding ability and cooking losses) characteristics of the porcine semimembranosus muscle.     

Effect of feed intake and exogenous porcine somatotropin on longissimus muscle fiber characteristics of pigs weighing 55 kilograms live weight

Thirty two barrows were used in a 2 x 3 factorial arrangement to evaluate the effects of porcine somatotropin (pST) administration (USDA-pGH-B1; 0 and 100 micrograms.kg BW-1.d-1) and feed intake (FI; ad libitum [A], 1.64 [R1:80% of A] and 1.38 [R2:60% of A] kg/d) on longissimus (LM) muscle fiber characteristics of pigs growing from 25 to 55 kg live weight. The administration of pST resulted in an increase (P less than .05) in muscle fiber size (all three fiber types) and shear-force (17.1%). The percentage of muscle fiber types was not affected by pST treatment. Feeding of the diet at restricted levels (R1 and R2) resulted in smaller (P less than .05) beta R and alpha W fibers compared with feeding ad libitum. Pigs with ad libitum access to their diet had fewer alpha R fibers and more alpha W fibers in the LM compared with those fed at R1 and R2 levels. Restricted feed intake (R1 and R2) resulted in lower (P less than .05) shear-force values compared with ad libitum feeding. The present study indicates that pST administration of young barrows results in an increase in muscle hypertrophy. Restricted FI reduces both transformation from alpha R to alpha W fibers and muscle fiber hypertrophy.     

The interrelationship between crude protein and exogenous porcine somatotropin on growth, feed and carcass measurements of pigs

In three experiments the interrelationship between dietary CP and recombinant porcine somatotropin (rpSt, i.m. daily) on ADG, feed efficiency (F/G) and carcass traits was examined in crossbred Yorkshire gilts and barrows given ad libitum access to their diets during the finishing period (55 to 110 kg BW). Pigs, blocked by BW and gender, were assigned (four/pen) within block. In Exp. 1, 140 pigs were assigned two/gender per pen to each of five pens/block and received a diet of either 12%, 18% or 24% CP (n = 2, 1 and 2 pens/block, respectively). Pigs received rpSt, either 0 or 120 micrograms/kg BW (12% and 24% CP groups) or 60 micrograms/kg BW (18% CP group). When CP was 12%, rpSt decreased ADG and increased F/G (P less than .05), whereas when CP was 18% or 24%, rpSt increased ADG and lowered F/G (P less than .05). Backfat thickness was reduced (P less than .05) by rpSt regardless of CP. In Exp. 2, 120 pigs were assigned two/gender per pen to each of five pens/block and received a diet of 24% CP. Either 0, 15, 30, 60 or 120 micrograms of rpSt/kg BW was administered to each pig. All doses of rpSt increased ADG, lowered F/G and decreased backfat thickness compared with measurements for control pigs (P less than .05). In Exp. 3, 140 pigs were assigned two/gender per pen to each of seven pens/block and received a diet of either 14%, 18% or 24% CP (n = 3, 2 and 2 pens/block, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of porcine somatotropin on in vivo glucose kinetics and lipogenesis in growing pigs.

Crossbred barrows were used for in vivo studies investigating hormonal regulation of lipogenesis. The first experiment examined an in vivo method for determining rates of lipogenesis. Three barrows were infused with [U-14C]glucose and incorporation of radioactivity into triglycerides was determined in up to five biopsies of subcutaneous adipose tissue obtained over 7 h. Incorporation was linear after blood glucose specific radioactivity had reached a plateau and was constant over the entire infusion. For the second experiment, eight pigs (71 +/- 2.5 kg) were allocated to one of two treatments involving daily injections of excipient (control) or porcine somatotropin (pST; 120 micrograms/kg of BW). On d 10, beginning 15 h after injection, glucose incorporation into adipose tissue lipid was determined under both basal and hyperinsulinemic/euglycemic conditions. Basal glucose incorporation into lipid, particularly fatty acids, was markedly reduced (greater than 90%) during pST treatment. Although glucose incorporation was increased to a similar extent in both groups by hyperinsulinemia, the pST-treated pigs still exhibited markedly lower rates. Based on kinetic data, the decrease in lipid accretion of pST-treated pigs was primarily the result of a decrease in the rate of de novo synthesis. Furthermore, the reductions in glucose incorporation into fatty acids, glucose irreversible loss rate, and feed intake that occur with pST treatment were quantitatively similar.     

Effects of exogenous porcine somatotropin administration between 30 and 60 kilograms on longissimus muscle fiber morphology and meat tenderness of pigs grown to 90 kilograms

Twenty-four barrows were used to investigate the effects of exogenous porcine somatotropin (pST) administration (0 and 100 micrograms.kg-1.d-1) between 30 and 60 kg on longissimus muscle morphology and meat tenderness of pigs grown to 90 kg. Administration of pST was by daily i.m. injection. Pigs were fed a fortified diet in restricted amounts between 30 and 60 kg and had ad libitum access to this diet from 60 to 90 kg. Excipient pigs had fewer alpha R fibers and more alpha W fibers than pST-treated pigs (P less than .05). Administration of pST increased (P less than .05) muscle fiber area for all three fiber types at both the 60 kg (34%) and 90 kg (29%) slaughter weights. Furthermore, pST administration increased shear-force (30% at 60 kg; 19% at 90 kg) of the longissimus muscle, indicating that pST administration reduced meat tenderness. All the pST-treated pigs exhibited the "giant fiber syndrome" and a high proportion (62%) of pST-treated pigs exhibited pale, soft, exudative muscle. Whether the giant fiber anomaly resulted from increased muscle protein accretion rate or fiber degeneration is unknown. Results indicated that the stimulatory effects of pST on muscle growth are sustained following cessation of hormone treatment. However, the incidence of pale, soft, exudative muscle in 62% of the pST-treated pigs indicates that pST potentially has undesirable side effects.     

Effect of somatotropin on nonesterified fatty acid and glycerol metabolism in growing pigs.

Eight crossbred barrows (71 kg initial BW) were allocated to two treatments involving daily i.m. injections of either excipient (control) or recombinantly derived porcine somatotropin (120 micrograms/kg of BW). On d 8 of treatment, beginning 15 h after injection, glycerol and nonesterified fatty acid (NEFA) kinetics were determined using a primed, continuous infusion of [2-3H]glycerol and [9,10(n)-3H]oleic acid. Kinetics were examined under both basal conditions and during a hyperinsulinemic/euglycemic clamp. Plasma concentrations of NEFA and glycerol and their respective entry rates were highly correlated. Insulin had no effect on plasma glycerol or glycerol entry rate, probably due to the very low rates that were observed in both the control and somatotropin-treated pigs. However, both plasma NEFA and oleic acid entry rate were reduced during hyperinsulinemia. Although indices of fat mobilization tended to be higher in pigs treated with somatotropin, the magnitude of the increases were small and would be sufficient to account for only a minor fraction of the decreased lipid accretion observed in somatotropin-treated pigs.     

Effects of recombinant porcine somatotropin on metabolic rate in growing pigs

Effects of recombinant porcine somatotropin (rpST) on metabolic rate were studied in two trials with 24 crossbred barrows (Yorkshire x Landrace) in each. The barrows weighed about 80 kg (SE within trials 2.2 kg) at the start of the measurements and in each trial 12 pigs received 4 mg of rpST and 12 received a placebo. The diet contained 2.57 Mcal NE/kg and 20% CP (about 1% lysine). Animals were fed approximately 2.8 times maintenance (280 kcal ME.kg-.75.d-1). Heat production (gaseous exchange of CO2 and O2) and activity were measured continuously. Heat production associated with activity was calculated from the regression of heat production on activity. Animals treated with rpST exceeded controls in rate of gain by 252 g/d (P less than .001) and in metabolic rate by 14.5 kcal.kg-.75.d-1 (P less than .01). The rpST treatment increased rectal (+ .2 degrees C) and surface (+ .8 degrees C) temperatures. Activity-related heat production in treated pigs was increased, but this was only partly related to the increase in metabolic rate with rpST. The daily patterns of total and activity-related heat production were similar between pigs in both experimental treatments.     

Effect of recombinant porcine somatotropin on energy and protein utilization by growing pigs: interaction with capacity for lean tissue growth.

Three litters of four pigs from each of four different groups were used to evaluate the effect of porcine somatotropin (pST) on growth performance, body gain composition, energy and N metabolism, and in vitro cytochrome oxydase (final enzyme of the respiratory chain) activity of tissues. The four groups included boars from a synthetic line (SG1) or the Large White breed (SG2) and barrows from the Large White breed (SG3) or crossbred between Large White and Meishan breeds (SG4). Inherent capacity for daily lean tissue growth (LTG) decreased from SG1 to SG4. Within a litter, one pig was slaughtered and dissected at the beginning of the experiment (55 kg BW) and the three others were fed the same daily supply of protein and amino acids (26 g of lysine/d) but relative daily energy levels were either 113 (without pST: E1/0), 100 (3 mg of pST/d: E2/pST) or 87 (3 mg of pST/d: E3/pST). The 100 energy level corresponded to the ad libitum intake of E2/pST pigs. Two energy and N balances were carried out in respiration chambers during the experimental period. Pigs were slaughtered and dissected at approximately 95 kg BW and composition of gain was estimated using the comparative slaughter technique. In E1/0 pigs, daily BW, lean, and N gain were affected (P less than .01) by group; 566, 471, 374, and 315 g/d of lean tissue gain in SG1, SG2, SG3, and SG4 pigs, respectively. At high ME intake (E2/pST vs E1/0), pST increased daily BW (+14%), lean (+27%), or N (+26%) gain and reduced adipose tissue (-50%) gain, but the pST effect was inversely related to LTG: for N, the improvement was 2.8, 7.1, 7.0, and 11.1 g/d in SG1, SG2, SG3, and SG4 groups, respectively. Energy restriction (E3/pST vs E2/pST) reduced (P less than .001) adipose tissue gain in all groups but did not affect lean tissue or N gains in SG1, SG2, and SG3 pigs. In the pST-treated pigs of the SG4 group, the lean tissue or N gains were reduced (P less than .01) by energy restriction. Energy restriction combined with pST treatment (E3/pST) led to negligible amounts of fat deposited (40 g/d for SG1 + SG2 + SG3 pigs) and a gain:feed ratio higher than 500 g/kg (580 in SG1 pigs). The increased heat production measured in pST-treated pigs was due to its maintenance component: 275 vs 257 kcal of ME.kg BW-.60.d-1 (P less than .01).(ABSTRACT TRUNCATED AT 400 WORDS)     

Effects of recombinant porcine somatotropin on growth and carcass traits in meishan pigs

Effects of recombinant porcine somatotropin (rpST) on growth, feed intake, feed conversion, back-fat thickness and lean percentage were examined in growing Meishan pigs. The experiment comprised 42 barrows of which 20 were administered 14 mg rpST twice a week i.m., starting at 40 kg, the others received a placebo. Pigs were fed ad libitum a diet containing 9.2 MJ net energy and 156 g crude protein kg⁻¹ and were slaughtered at 90 kg liveweight. From 40 to 90 kg liveweight, rpST effects were: daily gain +17.9%; feed intake −5.1%; feed conversion −17.5%; backfat thickness −29.8%; lean percentage +16.0%. The effects of rpST in Meishan are much larger than in a similar experiment with leaner western pigs. Development of synthetic breeds with Meishan in combination with the use of rpST in cross-bred fattening pigs may be a way to economically exploit the high fertility of Meishan.     

Effect of recombinant porcine somatotropin on lactational performance and metabolite patterns in sows and growth of nursing pigs

Sixteen crossbred sows (Yorkshire x Duroc) were used to determine the effect of recombinantly derived porcine somatotropin (pST) on lactational performance and the pattern of plasma metabolites and growth rate of nursing pigs. Daily s.c. injections of either pST (8.22 mg.sow-1.d-1) or excipient were administered at 1000 on d 12 through d 29 of lactation. Jugular cannulas were inserted in three sows/treatment and hourly blood samples were collected on d 11 to 13 and d 28 to 29 of lactation to determine the effect of treatment on plasma concentrations of somatotropin, glucose and nonesterified fatty acids in plasma. Milk production and weight of nursing pigs were determined pretreatment (d 9 and 10) and on d 16, 22 and 28. Milk production of sows receiving pST progressively increased above that of control sows and was 22% greater on d 28. Milk composition was not affected by treatment with pST (P greater than .10), so that the increase in yields of milk fat, lactose and solids paralleled the increases in milk yield. Total milk protein yield tended to be higher in sows receiving pST, but protein yield was greater (P less than .10) only on d 28. Pigs suckling sows treated with pST weighed .34 kg more at the end of the lactation period (P less than .05). Sows receiving pST consumed less feed (P less than .05) during the treatment period, and, as a result, lost more weight (P less than .10) and backfat (P less than .05) than control sows. Average concentrations of plasma somatotropin were elevated approximately 2.5-fold above baseline levels by exogenous pST. No acute alterations in plasma glucose or nonesterified fatty acids were observed in response to pST treatment, however, sows receiving pST had a chronic elevation of plasma glucose on d 29 of lactation.     

Effect of treatment with and subsequent withdrawal of exogenous porcine somatotropin on growth and reproductive characteristics of gilts

Two experiments were conducted to examine responses of gilts to treatment with and withdrawal of exogenous porcine somatotropin (PST). In Exp. 1, 36 prepubertal gilts (79.7 +/- .9 kg; 159.1 +/- .7 d) were allotted randomly to receive daily either 0 micrograms PST (C) or 70 micrograms PST/kg initial BW for either 21 (PST-3) or 42 d (PST-6). Gilts were examined for estrus daily by a mature boar starting on d 22 and continuing for up to 50 d. Gilts that expressed estrus were mated and removed from treatment. PST-treated gilts had higher ADG (P less than .01) and lower feed/gain (P less than .02) than C gilts. Following initiation of boar exposure, C gilts (mean interval to estrus = 2.0 d) exhibited estrus earlier than PST-3 (24.8 d) and PST-6 (24.0 d) gilts (P less than .07); however, only two C gilts were observed in estrus compared with six PST-3 and six PST-6 gilts. In Exp. 2, 40 prepubertal gilts (72.6 +/- 1.0 kg; 141.1 +/- .7 d) were allotted randomly to receive daily either 0 mg PST (C) or 5 mg PST for 30 d. On d 31, half the gilts were comingled with unfamiliar penmates and examined for estrus daily by a mature boar for up to 45 d. Estrual gilts were removed from treatment.(ABSTRACT TRUNCATED AT 250 WORDS)     

Influence of dietary protein and recombinant porcine somatotropin administration in young pigs: growth, body composition and hormone status

The influence of dietary protein and recombinant porcine somatotropin (rpST) administration on growth and body composition was investigated in barrows. Ten groups of six pigs starting at 30 kg were restrictively fed (approximately 80% of ad libitum) one of five diets containing 11, 15, 19, 23 or 27% protein. Diets contained skim milk (12%). Soybean meal diluted with cornstarch was used as the supplemental source of dietary protein. Diets were isocaloric (3.8 Mcal DE/kg) and all contained the same amount of lysine (18 to 20 g/kg). Thirty pigs were treated daily with rpST (100 micrograms/kg) by i.m. injection; the remaining pigs were treated with sterile diluent (control) for 42 d. Growth rate was greater in rpST-treated pigs at all levels of protein intake; however, the magnitude of the response to rpST treatment was lowest among pigs fed the diet containing 11% protein. Feed:gain ratio, backfat depth and carcass fat content were decreased in rpST-treated pigs compared to respective controls. Additionally, the concentration of carcass fat decreased concomitantly with an increase in dietary protein intake. Concentration of carcass protein increased linearly as dietary protein increased in control and rpST-treated pigs. In contrast, treatment with rpST was associated with an increased visceral mass; the concentration of protein and fat in the viscera was influenced by protein intake but not by rpST. These results, characterized by few treatment interactions, suggest that when energy intake is kept constant and appropriately fed pigs serve as controls, dietary protein and rpST influence growth and body composition by independent mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of gender and genotype on the response of growing pigs to exogenous administration of porcine growth hormone

Sixty crossbred pigs (Large White x Landrace) were used in a 2 x 2 x 2 factorial experiment to investigate the effects of gender (intact males vs females) and strain (A vs B) on the response to exogenous porcine growth hormone (pGH) administration (0 [excipient-treated] vs .1 mg pGH.kg live weight-1.d-1). All pigs had ad libitum access to their diet; pGH was administered daily from 60 to 90 kg live weight. All aspects of growth performance and body composition were affected to different degrees by gender and pGH. Strain A pigs had a higher capacity for protein accretion, superior growth performance and contained less fat in the eviscerated carcass and empty body compared with Strain B pigs. Within each strain, intact males ate more feed, had a higher rate of protein deposition and exhibited faster and leaner growth than females. Exogenous pGH administration increased average protein deposition and growth rate by 84 and 34%, respectively, and reduced average feed intake, fat deposition rate, feed:gain and carcass fat content by 14, 59, 37 and 33%, respectively. The magnitude of the changes in growth performance, tissue accretion rates and body composition elicited by pGH were independent of strain. However, within each strain the improvement in feed:gain and reduction in carcass fat measurements elicited by pGH were proportionately larger for females than for intact males.     

Effects of porcine somatotropin administration on the responses to dietary lysine and a near-ideal blend of amino acids for growing pigs

Two experiments were conducted to assess the effects of porcine ST (pST) on the responses to a near-ideal blend of AA for pigs from 22 to 60 kg BW. Eighty Hampshire × Yorkshire gilts (40 gilts/experiment) were individually penned and assigned to a 4 × 2 factorial arrangement of treatments, consisting of 4 diets with and without pST injection. A fortified corn-soybean meal basal diet was formulated to contain 1.50% total Lys and Thr, Met, and Trp were added to obtain a near-ideal blend of these AA relative to Lys. In 3 additional diets, Lys was reduced to 1.25%, 1.00%, or 0.75% by diluting the basal diet with cornstarch, cellulose, and sand, such that the diets also contained the same ratios of AA. Pigs that received pST were administered a daily intramuscular injection of 2 mg of pST. Data from the 2 experiments were pooled. Administration of pST increased ADG (P < 0.01), G:F (P < 0.01), and LM area (P < 0.01), and decreased ADFI (P < 0.03), last rib backfat (P < 0.01), and 10th rib backfat (P < 0.01). Also, estimated carcass muscle and calculated lean gain increased (P < 0.01) in pST-treated pigs. Administration of pST also increased (P < 0.01) the percentage, total gain and accretion rate of water, protein, and ash in the carcass, and decreased (P < 0.01) the percentage, total gain, and accretion rate of carcass fat. Growth rate, G:F, and carcass traits improved (P < 0.01), percentage of carcass proteinand water increased (P < 0.01), and carcass fat percentage decreased (P < 0.01) with increasing dietary Lys. The percentage, total gain, and accretion rate of carcass protein increased to a greater extent in pST-treated pigs than in untreated pigs, resulting in a pST × Lys interaction (P < 0.05). The results indicated that pST improves performance, leanness, and protein accretion in pigs from 22 to 60 kg BW, and that these responses to dietary Lys and a near-ideal blend of AA is greater in growing pigs treated with pST than untreated pigs.     

Effect of conjugated linoleic acid on energy metabolism in growing-finishing pigs

The effect of conjugated linoleic acid (CLA) on energy metabolism was studied in a respiration experiment with 20 growing pigs. From 70 kg liveweight onwards the animals received isoenergetic rations containing 0 or 3% CLA on the basis of metabolic bodyweight. Between 95 and 100 kg liveweight the gas exchange of each animal was measured over 48 h in a respiration chamber. This was preceded by a 5‐day quantitative determination of faeces and urine. The heat production and energy retention of the animals were determined by the carbon–nitrogen balance technique and the RQ method. Additionally several parameters of blood serum were determined. CLA had no effect on digestibility and metabolizability of energy, nor were gas exchange and heat production (HP) of the animals affected by the treatment. Average heat production across all measurements was 628 kJ/kg W^0.75 in the control group and 636 kJ/kg W^0.75 in the CLA group. No difference in fat deposition was observed (control 386, CLA group 379 kJ/kgW^0.75). The N balance on the other hand was 2.2 g/day higher in the CLA‐supplemented animals. This caused retained protein energy, as a proportion of total energy retention, to increase from 24.2 to 25.8%. The ratio of retained protein energy to fat energy was 10% higher in the CLA‐treated animals than in the controls. Body mass increase over the trial as a whole was unaffected (control 27.6, CLA group 28.1 kg, equivalent to daily gains of 931 and 946 g, respectively). Blood serum lipoproteins exhibited few CLA‐induced changes. The greatest effects were observed in triacylglycerols, which were raised in the CLA animals compared with the controls. The ratio of cholesterol‐low‐density lipoprotein to cholesterol‐high‐density lipoprotein rose by 17% as a result of CLA treatment. Serum concentrations of albumin, creatinine, urea and glucose were unchanged. In conclusion, the study showed that supplementation with CLA under isoenergetic feeding conditions with a strongly positive energy balance has no marked effect on total metabolism, although a slightly enhanced deposition of protein was evident.     

Lysine requirement of finishing pigs administered porcine somatotropin by sustained-release implant

To alleviate the need for daily injection of porcine somatotropin (pST), a sustained-release implant (pSTSR) was devised that continuously delivers a daily dose of 2 mg of pST for 42 d. Ninety-six white composite (Large White x Landrace) finishing barrows (83.6 +/- 1.2 kg BW) were assigned to receive zero or two pSTSR implants (4 mg pST/d) and to consume one of six diets differing in total Lys concentration (0.29, 0.52, 0.75, 0.98, 1.21, or 1.44%, as-fed basis). Diets were formulated to be isocaloric and based on the ideal protein concept. Pigs were housed individually, allowed ad libitum access to feed and water, and slaughtered at 112 kg of BW. The pSTSR affected neither ADG (P = 0.88) nor 10th rib LM area (LMA; P = 0.51), but it decreased (P < 0.01) ADFI, average backfat thickness, 10th rib fat depth, weights of leaf fat and ham fat, improved (P < 0.05) G:F, and increased (P < 0.01) weights of four trimmed lean cuts (T-cuts), and percentages of ham lean and bone. Increasing total Lys increased ADG (quadratic; P < 0.05) and ADFI (linear; P < 0.01). The G:F, plasma urea N concentrations (PUN), and T-cuts were affected by the interaction pSTSR x dietary Lys (P < 0.01). Without pSTSR, the G:F did not differ (P = 0.37) among pigs fed 0.52% and greater total Lys. With pSTSR, the G:F was less (P < 0.05) for pigs fed 0.52% than 0.98 and 1.44% total Lys. Increases in dietary total Lys resulted in increased PUN (P < 0.01), and incremental increases were less in pSTSR-implanted pigs. Maximal yield of T-cuts was at 0.98% dietary total Lys in nonimplanted pigs and 1.21% total Lys in pSTSR-implanted pigs. Estimates of total Lys requirements of pigs without and with pSTSR, respectively, were 0.52 and 0.86% for growth (ADG and G:F) and 0.73 and 0.88% for lean production (LMA and T-cuts). Equivalent apparent ileal digestible Lys requirements of pigs without and with pSTSR, respectively, were 0.44 and 0.68% for growth, and 0.62 and 0.75% for lean production. With ADFI of 3.5 kg daily, an intake of approximately 26.1 g of total daily Lys (0.75%) or 22.4 g of apparent ileal digestible Lys is needed to maximize lean production in finishing barrows receiving 4 mg pST/d via sustained-release implant.     

Effect of a high-fat diet on the performance response to porcine somatotropin (PST) in finishing pigs

One hundred sixty pigs were used in a 2 x 2 factorial design to compare the performance response to daily injection of porcine somatotropin (PST); (0 or 2 mg/d) in animals fed a 14% CP corn-soy diet (control, C) to those fed a diet with 10% added fat (F) and calorie:protein and lysine:protein ratios similar to that of the C diet. Treatments, assigned randomly to 20 pens (n = 5/treatment) of eight pigs each, were initiated at 90 kg body weight and continued for 28 d. Responses to PST and dietary fat were typical. These include improved gain and feed efficiency and decreased feed intake. The effects of dietary fat on intake and efficiency were accounted for largely by the difference in energy density of these diets. Across diets, PST treatment resulted in a 13% improvement in ADG (P less than .001), a 13% decrease in feed intake (P less than .0001) and a 22% improvement in efficiency (P less than .0001). Of particular interest were the additive (PST x diet interaction, P less than .2) effects of PST and dietary fat on gain in these animals. Pigs treated with PST that were fed the F diet had greater rates of gain than did PST-treated pigs fed the C diet (P less than .05). Treatment with PST increased ADG by 9% in pigs consuming the C diet vs 16% in pigs fed the F diet. Similarly, dietary fat resulted in 4 and 11% increases in ADG in pigs treated with 0 or 2 mg of PST/d.(ABSTRACT TRUNCATED AT 250 WORDS)     

Interaction of dietary protein content and exogenous porcine growth hormone administration on protein and lipid accretion rates in growing pigs

Sixty-six intact male pigs were used to investigate the relationships between exogenous porcine growth (pGH) administration (0, excipient-treated, and .09 mg recombinant pGH.kg-1.d-1) and dietary protein content (8.3, 11.4, 14.5, 17.6, 20.7 and 23.8%) on protein and lipid accretion rates over the live weight range of 30 to 60 kg. Feed intakes were restricted (1.84 kg.pig-1.d-1) and pGH was administered daily by i.m. injection. Rate of protein deposition increased with increasing dietary protein up to 17.6 and 20.7%, respectively, for control and pGH-treated pigs; both growth and protein deposition were enhanced by pGH on the four higher protein diets but remained unaffected by pGH administration to pigs given the two lowest protein diets. Plasma IGF-I concentration was elevated by pGH administration in pigs given the four higher protein diets but unaffected by pGH with the two lowest protein diets. Rate of fat deposition was depressed on all dietary protein treatments by pGH administration; carcass fat content of control and pGH-treated pigs declined with each increase in dietary protein up to 17.6 and 23.8%, respectively. The results demonstrate that pGH acts independently on protein and lipid metabolism.